Mylan Institutional recalls

Mylan Institutional has 24 recalls on record with the FDA and USDA, the earliest in 2015 and the latest reported on 26 Mar 2025. 8 are still ongoing. The most frequent reason is potency & assay.

Total recalls24since 2015

Last 12 months0reported

Class I1042% of total

Ongoing8latest 26 Mar 2025

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 6 0Jan '25 0 2 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 10 42%Class II 11 46%Class III 3 13%

Why mylan institutional is recalled

Product types

Injectable & IV Drugs1667%
Thyroid Medication833%

Brands

By year

202528%
2024625%
202114%
2020417%
201914%
20151042%

Ongoing mylan institutional recalls

8 active

Reported	Class	Recall	Company	Reason	Where
26 Mar 2025Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 150 mcg 15 mg) recalledLevothyroxine Sodium	Mylan Institutional	Potency & Assay	Nationwide
26 Mar 2025Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 125 mcg 125 mg) recalledLevothyroxine Sodium	Mylan Institutional	Potency & Assay	Nationwide
18 Dec 2024Drug	CLASS II	Levothyroxine Sodium Tablets recalled by Mylan InstitutionalLevothyroxine Sodium	Mylan Institutional	Potency & Assay	Nationwide
18 Dec 2024Drug	CLASS II	Levothyroxine Sodium Tablets recalled by Mylan InstitutionalLevothyroxine Sodium	Mylan Institutional	Potency & Assay	Nationwide
18 Dec 2024Drug	CLASS II	Levothyroxine Sodium Tablets recalled by Mylan InstitutionalLevothyroxine Sodium	Mylan Institutional	Potency & Assay	Nationwide
18 Dec 2024Drug	CLASS II	Levothyroxine Sodium Tablets recalled by Mylan InstitutionalLevothyroxine Sodium	Mylan Institutional	Potency & Assay	Nationwide

All mylan institutional recalls, newest first

24 total

Reported	Class	Recall	Company	Reason	Where
26 Mar 2025Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 150 mcg 15 mg) recalledLevothyroxine Sodium	Mylan Institutional	Potency & Assay	Nationwide
26 Mar 2025Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 125 mcg 125 mg) recalledLevothyroxine Sodium	Mylan Institutional	Potency & Assay	Nationwide
18 Dec 2024Drug	CLASS II	Levothyroxine Sodium Tablets recalled by Mylan InstitutionalLevothyroxine Sodium	Mylan Institutional	Potency & Assay	Nationwide
18 Dec 2024Drug	CLASS II	Levothyroxine Sodium Tablets recalled by Mylan InstitutionalLevothyroxine Sodium	Mylan Institutional	Potency & Assay	Nationwide
18 Dec 2024Drug	CLASS II	Levothyroxine Sodium Tablets recalled by Mylan InstitutionalLevothyroxine Sodium	Mylan Institutional	Potency & Assay	Nationwide
18 Dec 2024Drug	CLASS II	Levothyroxine Sodium Tablets recalled by Mylan InstitutionalLevothyroxine Sodium	Mylan Institutional	Potency & Assay	Nationwide
18 Dec 2024Drug	CLASS II	Levothyroxine Sodium Tablets recalled by Mylan InstitutionalLevothyroxine Sodium	Mylan Institutional	Potency & Assay	Nationwide
18 Dec 2024Drug	CLASS II	Levothyroxine Sodium Tablets recalled by Mylan InstitutionalLevothyroxine Sodium	Mylan Institutional	Potency & Assay	Nationwide
9 Jun 2021Drug	CLASS III	Thiamine HCl Injection, USP 200 mg/ (100mg/mL) vials recalledThiamine Hydrochloride	Mylan Institutional	Packaging Defects	Nationwide
9 Sep 2020Drug	CLASS I	Amiodarone Hydrochloride Injection, USP, 450 mg recalledAmiodarone Hydrochloride	Mylan Institutional	Packaging Defects	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.